Drug information for TRIZIVIR

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
TABLET; ORAL	EQ 300MG BASE;150MG;300MG	Prescription	(Reference Drug)	ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE	Trizivir	VIIV HLTHCARE	21205 2012-03-13 Letter 2012-03-12 Label 2011-11-25 Medication Guide 2011-11-25 Label 2011-11-22 Letter 2011-05-17 Letter 2011-04-04 Letter 2011-04-01 Label 2010-08-10 Letter 2010-08-10 Medication Guide 2009-12-18 Other 2009-05-29 Medication Guide 2009-04-03 Label 2009-03-11 Letter 2007-07-09 Review 2007-07-09 Review 2007-07-09 Review 2007-07-09 Review 2007-07-09 Review 2007-07-09 Review 2007-05-09 Label 2007-05-09 Letter 2006-08-18 Letter 2006-08-14 Label 2005-05-17 Label 2005-05-17 Letter 2005-04-08 Review 2005-03-08 Review 2005-03-08 Review 2004-06-28 Letter 2004-06-28 Label 2004-03-28 Review 2004-03-01 Letter 2004-03-01 Letter 2002-10-08 Label 2002-10-08 Letter 2002-08-13 Label 2002-08-13 Letter 2002-06-04 Label 2002-02-05 Letter

Drug Adverse Effects information for TRIZIVIR

Role code	Indications	Reaction	# Reports
PS	ANTIRETROVIRAL THERAPY	ABDOMINAL DISTENSION	4
PS	ANTIRETROVIRAL THERAPY	BONE MARROW FAILURE	4
PS	ANTIRETROVIRAL THERAPY	CHILLS	4
PS	ANTIRETROVIRAL THERAPY	CYTOLYTIC HEPATITIS	4
PS	ANTIRETROVIRAL THERAPY	CYTOMEGALOVIRUS HEPATITIS	4
PS	ANTIRETROVIRAL THERAPY	DIARRHOEA	4
PS	ANTIRETROVIRAL THERAPY	FOETAL EXPOSURE DURING PREGNANCY	2
PS	ANTIRETROVIRAL THERAPY	HEPATOTOXICITY	4
PS	ANTIRETROVIRAL THERAPY	HYPERSENSITIVITY	4
PS	ANTIRETROVIRAL THERAPY	IMMUNE RECONSTITUTION SYNDROME	4
PS	ANTIRETROVIRAL THERAPY	INTRA-UTERINE DEATH	2
PS	ANTIRETROVIRAL THERAPY	MATERNAL EXPOSURE DURING PREGNANCY	2
PS	ANTIRETROVIRAL THERAPY	NAUSEA	4
PS	ANTIRETROVIRAL THERAPY	PYREXIA	4
PS	ANTIRETROVIRAL THERAPY	RASH PAPULAR	4
PS	ANTIRETROVIRAL THERAPY	STILLBIRTH	2
PS	ANTIRETROVIRAL THERAPY	SWELLING FACE	4
PS	ANTIRETROVIRAL THERAPY	TRANSAMINASES INCREASED	4
PS	ANTIRETROVIRAL THERAPY	UMBILICAL CORD AROUND NECK	2
PS	HIV INFECTION	LIPODYSTROPHY ACQUIRED	1
PS	HIV INFECTION	RENAL IMPAIRMENT	1
PS	HIV INFECTION	WEIGHT DECREASED	1
SS	ANTIRETROVIRAL THERAPY	ANAEMIA	3
SS	MATERNAL EXPOSURE TIMING UNSPECIFIED	FOETAL EXPOSURE DURING PREGNANCY	2
SS	MATERNAL EXPOSURE TIMING UNSPECIFIED	UMBILICAL CORD AROUND NECK	2
SS	PRODUCT USED FOR UNKNOWN INDICATION	MENTAL DISORDER	2
C	ABSTAINS FROM ALCOHOL	DEATH	4
C	ANXIETY	DEATH	4
C	DYSLIPIDAEMIA	DRUG INTERACTION	1
C	DYSLIPIDAEMIA	HYPONATRAEMIA	1
C	DYSLIPIDAEMIA	RESPIRATORY TRACT INFECTION	1
C	HEPATIC CIRRHOSIS	DRUG INTERACTION	1
C	HEPATIC CIRRHOSIS	HYPONATRAEMIA	1
C	HEPATIC CIRRHOSIS	RESPIRATORY TRACT INFECTION	1
C	HIV INFECTION	ALANINE AMINOTRANSFERASE INCREASED	1
C	HIV INFECTION	ASPARTATE AMINOTRANSFERASE INCREASED	1
C	HIV INFECTION	DEATH	4
C	HIV INFECTION	OSTEONECROSIS	10
C	HYPERTENSION	DRUG INTERACTION	2
C	HYPERTENSION	HYPONATRAEMIA	2
C	HYPERTENSION	RESPIRATORY TRACT INFECTION	2
C	PROPHYLAXIS	DRUG INTERACTION	2
C	PROPHYLAXIS	HYPONATRAEMIA	2
C	PROPHYLAXIS	RESPIRATORY TRACT INFECTION	2
C	SMOKING CESSATION THERAPY	DEATH	16

Ads by Google